AMGN

Recent Articles

5 Blue-Chip Stocks to Sell for December

These five stocks to sell appear to be likely losers for December thanks to garbage charts and a weak history in a historically robust month. More 

3 Beaten-Down Biotech Stocks to Buy for Huge Gains

The following are three Biotech stocks to buy because of their long-term potential, which surpasses the recent onslaught of negative press and concern over higher drug prices. More 

3 Stocks to Watch on Wednesday: Amgen, Inc. (AMGN), Cisco Systems, Inc. (CSCO) and NetApp Inc. (NTAP)

Amgen (AMGN) had positive late-stage trial results, while Cisco (CSCO) and NetApp (NTAP) were moving in different directions on earnings news. More 

52 Biotechnology Stocks to Sell Now

The overall ratings of 52 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

5 Top Biotech Stocks to Buy on Trump Victory

The case for buying biotech stocks has strengthened following the election of Donald Trump to the White House. More 

27 Biotechnology Stocks to Sell Now

This week, 27 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

Corporate Tax Rates: 10 U.S. Companies Paying the Highest Taxes, 10 U.S. Companies Paying the Lowest Taxes

WalletHub has released its list of the companies in the United States with the highest, and the lowest, corporate tax rates. More